Lawrence J. Jasinski - 11 Dec 2021 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Director
Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Issuer symbol
LMAT
Transactions as of
11 Dec 2021
Net transactions value
+$27,994
Form type
4
Filing time
14 Dec 2021, 15:19:46 UTC
Previous filing
07 Jul 2022
Next filing
28 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Award $27,994 +576 +6.9% $48.60 8,909 11 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Stock Option (Right to Buy) Award $0 +3,444 $0.000000 3,444 11 Dec 2021 Common Stock 3,444 $48.60 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining two years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.
F2 This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years.